---
title: Genevoyager (Wuhan) Co., Ltd. vs uBriGene
slug_a: genevoyager-2
slug_b: ubrigene
site: cro
review_signal_gate: closed
canonical_path: /compare/genevoyager-2/ubrigene
---

# Genevoyager (Wuhan) Co., Ltd. vs uBriGene

Side-by-side profile data from each company listing on this directory.

## Genevoyager (Wuhan) Co., Ltd.

- Profile: [/companies/genevoyager-2](/companies/genevoyager-2)

Genevoyager (Wuhan) Co., Ltd. — Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.

Services: 3. Modalities: 3. Indications: 0. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (3).

### Services

- Regulatory Affairs
- Analytical Method Development & Validation
- Translational Research

### Modalities

- Biologics (Other)
- Vaccine
- AAV / Viral Vector Platform

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## uBriGene

- Profile: [/companies/ubrigene](/companies/ubrigene)

uBriGene — uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. The strongest documented coverage currently appears in services (5).

### Services

- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- China NMPA Regulatory Strategy
- Analytical Method Development & Validation
- Translational Research

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)